Blood Proteins Identified That Predict Multiple Sclerosis Early
May 26, 2026 Summary: Researchers identified a distinct cluster of blood proteins that alter in individuals who later develop multiple sclerosis…
AI Regulation & Transparency in Radiology with Dr. Hugh Harvey (ECR25)
Driving Responsible Innovation: AI Regulation & Transparency in Radiology As AI rapidly reshapes radiology, the conversation around regulation and trust…
Stuart Schlossman
This Blood Test Tracks MS Activity? (Octave Explained)
What happens if you ignore early symptoms of multiple sclerosis? In this video, Dr. Boster shares a real patient story…
Stuart Schlossman
MRI and MS diagnosis
Written by Lila Levinson, PhD | Last updated Feb. 27, 2026 Fact-checked by Inês Martins, PhD Magnetic resonance imaging (MRI), which produces detailed…
Stuart Schlossman
New biomarker may help identify MS patients for BTK inhibitors
Balance between 2 molecules seen as inflammation marker Written by Marisa Wexler, MS | January 7, 2026 The balance between two immune signaling…
Stuart Schlossman
What people with MS and care partners need to know about advancements in monitoring MS activity
Biomarkers are measurable tests such as blood tests, spinal fluid tests and MRI that can help your neurologist diagnose and…
Stuart Schlossman
video: Moderated & Public Q&A with MS Neurologists Boster and LaGanke
Event date: July 26, 2025 Moderator: Stuart Schlossman, President of MS Views and News / MS Patient Advocate At the…
Stuart Schlossman
AI tool effectively measures MS disease activity from 1 MRI scan
MindGlide to be used in research to assess brain damage, treatment by Marisa Wexler, MS | April 9, 2025 A…
Stuart Schlossman
A LOOK at Holistic & Mainstream Approaches to Multiple Sclerosis
No excerpt…
Stuart Schlossman
Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…
Stuart Schlossman
